[Effectiveness and disposition of the newly developed cephalosporin cefquinome in puerperal septicemia and toxemia in gilts].
Epizootiological, clinical, bacteriological and haematological studies were carried out to assess the effectiveness of the recently developed cephalosporin preparation Cefquinome in the treatment of the puerperal septicaemia and toxaemia syndrome. Cefquinome was administered at three different doses (1, 2 and 4 mg/kg BW) to 188 sows with feverish puerperal illness. Amoxicillin (7 mg/kg BW) was used as a control drug. In 41% of cases endometritis was a monoinfection whereas in 70% of mammary infections mixed infections were diagnosed. Results showed that for therapy of puerperal septicaemia and toxaemia Cefquinome at doses of 2 mg/kg BW and 4 mg/kg BW is clearly more effective than the control drug Amoxicillin and Cefquinome at its lowest dose of 1 mg/kg BW.
D000658:Amoxicillin / Q000627:therapeutic use; D000818:Animals; D002511:Cephalosporins / Q000494:pharmacology / Q000627:therapeutic use*; D004716:Endometritis / Q000188:drug therapy / Q000662:veterinary; D005260:Female; D008826:Microbial Sensitivity Tests; D011644:Puerperal Disorders / Q000188:drug therapy / Q000382:microbiology / Q000662:veterinary*; D018805:Sepsis / Q000188:drug therapy / Q000662:veterinary*; D013552:Swine; D013553:Swine Diseases / Q000188:drug therapy*; D013577:Syndrome; D014115:Toxemia / Q000188:drug therapy / Q000662:veterinary*